- All sections
- C - Chemistry; metallurgy
- C12N - Microorganisms or enzymes; compositions thereof; propagating, preserving, or maintaining microorganisms; mutation or genetic engineering; culture media
- C12N 15/10 - Processes for the isolation, preparation or purification of DNA or RNA
Patent holdings for IPC class C12N 15/10
Total number of patents in this class: 15575
10-year publication summary
|
775
|
925
|
1109
|
1432
|
1466
|
1649
|
1709
|
1666
|
1659
|
473
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| President and Fellows of Harvard College | 5792 |
387 |
| Massachusetts Institute of Technology | 9795 |
362 |
| The Regents of the University of California | 18943 |
347 |
| The Broad Institute, Inc. | 1584 |
314 |
| Illumina, Inc. | 2771 |
263 |
| Qiagen GmbH | 913 |
178 |
| 10X Genomics, Inc. | 921 |
166 |
| The Board of Trustees of the Leland Stanford Junior University | 6054 |
128 |
| Bio-Rad Laboratories, Inc. | 1592 |
117 |
| The General Hospital Corporation | 4517 |
109 |
| Life Technologies Corporation | 3068 |
108 |
| Twist Bioscience Corporation | 217 |
107 |
| Inscripta, Inc., FORMERLY Muse Biotechnology, Inc. | 300 |
106 |
| Pioneer Hi-Bred International, Inc. | 6264 |
97 |
| University of Vienna | 109 |
85 |
| Illumina Cambridge Limited | 678 |
81 |
| F. Hoffmann-La Roche AG | 7958 |
80 |
| Regeneron Pharmaceuticals, Inc. | 3650 |
71 |
| Becton, Dickinson and Company | 6712 |
69 |
| Immatics Biotechnologies GmbH | 1144 |
68 |
| Other owners | 12332 |